Skip to main content

Want a detailed portfolio tracker?

Klotho Neurosciences Inc Com (KLTO) P/E (2024 - 2026)

Klotho Neurosciences Inc Com (KLTO) P/E from Sep 17, 2024 to Jun 3, 2026. The TTM Klotho Neurosciences Inc Com (KLTO) P/E is -2.07. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Klotho Neurosciences Inc Com (KLTO)

YearP/EChange
2026-2.07+52.75%
2025-1.36+42.91%
2024-0.95N/A

Comparison Klotho Neurosciences Inc Com (KLTO) P/E with competitors

Klotho Neurosciences Inc Com (KLTO) P/E is -2.07.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.08%
NBYStablecoin Development Corp0.10-104.94%
ENLVEnlivex Therapeutics Ltd0.15-107.25%
FGENFibroGen Inc0.24-111.59%
TRAWTraws Pharma Inc0.47-122.83%
FBIOFortress Biotech Inc0.71-134.09%
CHRSCoherus Biosciences Inc0.98-147.23%
ORMPOramed Pharmaceuticals Inc1.47-171.15%
AGENAgenus Inc2.05-198.92%
VIVSVivoSim Labs Inc2.54-222.45%
INVAInnoviva Inc3.19-253.97%
CRMDCorMedix Inc3.65-276.05%
ABEOAbeona Therapeutics Inc4.20-303.06%
VXRTVaxart Inc4.26-305.80%
CVACCureVac N.V.4.45-314.68%
SRPTSarepta Therapeutics Inc4.62-323.31%
GLPGGalapagos NV4.86-334.64%
RIGLRigel Pharmaceuticals4.92-337.57%
ZVRAZevra Therapeutics Inc4.97-340.20%
ABUSArbutus Biopharma Corp5.69-374.95%
CGENCompugen Ltd7.38-456.58%
AUPHAurinia Pharmaceuticals Inc9.25-546.76%
ACADAcadia Pharmaceuticals Inc9.59-563.02%
OMEROmeros Corporation9.88-577.28%
PLXProtalix BioTherapeutics Inc9.91-578.52%
SPROSpero Therapeutics Inc10.73-618.39%
ADMAAdma Biologics Inc11.33-647.17%
SVASinovac Biotech Ltd11.44-652.26%
TBPHTheravance Biopharma Inc11.78-668.71%
HRMYHarmony Biosciences Holdings Inc12.18-688.21%
TGTXTG Therapeutics Inc13.18-736.45%
INCYIncyte Corp13.38-746.24%
SABSSAB Biotherapeutics Inc14.06-778.87%
XOMAXOMA Corp14.95-821.73%
REGNRegeneron Pharmaceuticals Inc14.98-823.42%
PBYIPuma Biotechnology Inc15.05-826.81%
EXELExelixis Inc15.79-862.76%
NAGENiagen Bioscience Inc16.35-889.80%
CPRXCatalyst Pharmaceuticals Inc17.34-937.60%
MDXGMimedx Group Inc17.38-939.08%
ARGXArgen X SE23.07-1214.16%
HALOHalozyme Therapeutics Inc23.20-1220.39%
XOMAOXOMA Corp25.34-1323.94%
VRTXVertex Pharmaceuticals Inc25.66-1338.96%
XOMAPXOMA Corp25.67-1339.65%
CTMXCytomX Therapeutics Inc25.70-1340.99%
ASNDAscendis Pharma A/S26.35-1372.68%
RPRXRoyalty Pharma plc - Class A27.50-1427.79%
SLNOSoleno Therapeutics Inc29.02-1501.19%
LGNDLigand Pharmaceuticals Inc - Class B30.19-1557.75%
BMRNBiomarin Pharmaceutical Inc37.51-1911.28%
APLSApellis Pharmaceuticals Inc39.02-1984.39%
KRYSKrystal Biotech Inc39.70-2017.06%
GMABGenmab40.20-2041.49%
ONCBeiGene Ltd67.03-3336.83%
TECHBio-Techne Corp68.59-3412.56%
VCELVericel Corp80.63-3993.71%
PHARPharming Group N.V.87.74-4337.11%
ALNYAlnylam Pharmaceuticals Inc124.93-6133.24%
TLXTelix Pharmaceuticals Ltd139.89-6855.54%
CORTCorcept Therapeutics Inc158.39-7748.86%